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Abstract
The inhibitory effects of Chinonin, a natural antioxidant extracted from a Chinese medicine, on apoptotic and necrotic cell
death of cardiomyocytes in hypoxia-reoxygenation process were observed in this study. The possible mechanisms of
Chinonin on scavenging reactive oxygen species and regulating apoptotic related genes bcl-2 and p53 were also investigated.
Neonatal rat cardiomyocytes were subjected to 24-h hypoxia and 4-h reoxygenation. Cell death was evaluated by DNA
electrophoresis on agarose gel, cell death ELISA and annexin-V-FLUOS/propidium iodide (PI) double staining cytometry.
Hypoxia caused the increase of apoptotic rates and the release of lactate dehydrogenase (LDH), while reoxygenation not only
further increased the apoptotic rates and leakage of LDH, but also induced necrosis of cardiomyocytes. In addition, hypoxia
increased the levels of NO32 /NO
3
3 and thiobarbituric acid reacted substances (TBARS), while reoxygenation decreased NO
3
2 /
NO33 , but further increased TBARS in the cultured media. Moreover, hypoxia up-regulated the expression levels of bcl-2 and
p53 proteins, while reoxygenation down-regulated bcl-2 and further up-regulated p53. Chinonin significantly decreased the
rates of apoptotic and necrotic cardiomyocytes, and inhibited the leakage of LDH. It also diminished NO32 /NO
3
3 and
TBARS, down-regulated the expression level of p53 protein, and up-regulated bcl-2 protein, respectively. The results suggest
that Chinonin has preventive effects against apoptotic and necrotic cell death and its protective mechanisms are related to the
antioxidant properties of scavenging nitric oxide and oxygen free radicals, and the modulating effects on the expression levels
of bcl-2 and p53 proteins. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Chinonin is an e¡ective component isolated from
Chinese herb Rhizoma anemarhenea which has been
used for several thousand years. Its chemical name is
2-(-D-glucopyranosyl-1,3,6,7-tetrahydroxyl-9H-xan-
thin-9-tone (Fig. 1). Our previous study implied that
Chinonin had scavenging e¡ects on nitric oxide (NO)
and oxygen free radicals and its antioxidant proper-
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Abbreviations: NO, nitric oxide; TBARS, thiobarituric acid
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NG-monomethyl-L-arginine; NOS, NO synthase; DMEM, Dul-
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£avin adenine dinucleotide; PI, Propidium iodide; Ara C, cyto-
sine arabinoside; PS, phosphatidylserine; CN, Chinonin
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ties were responsible for its cardioprotective e¡ects
against myocardial ischemia-reperfusion injury [1].
A recent study showed that Chinonin could inhibit
acute hypoxic pulmonary vasoconstriction and pre-
vent hypoxia-induced increase of mean pulmonary
arterial pressure by blocking the action of endothe-
lin-1 and/or platelet activating factor [2]. It implied a
potential clinical usage of preventing tissue damage
induced by ischemia or hypoxia. In order to further
elucidate the cardioprotective e¡ects of Chinonin,
we investigated the e¡ects of Chinonin on prevent-
ing cardiomyocytes from the apoptotic and necrotic
cell death during hypoxia and reoxygenation pro-
cess.
Much evidence shows that apoptosis can be in-
duced by ischemia or ischemia-reperfusion in many
di¡erent tissues, such as heart [3^6,9^11], brain [7],
liver [8], kidney [9], etc. Apoptosis may be the major
initial form of ischemic myocardial cell death occur-
ring within the ¢rst 2 and 3 h, and necrotic cell death
follows apoptosis and contributes to the evolution of
myocardial infarction [10]. However, the precise
mechanisms of apoptosis are ambiguous and the pre-
vention of apoptosis is seldom reported in myocar-
dial ischemia-reperfusion injury. Oxygen free radicals
are considered as important mediators of apoptosis
[11^13]. It may lead to the formation of oxidized
lipid in cell membranes [14], the activation of poly-
ADP-ribose transferase and accumulation of p53,
which are associated with apoptosis [15,16]. As a
kind of free radicals, NO is also involved in the
apoptotic process [17]. In hypoxic cardiomyocytes,
NO is produced by means of activating cyclic
GMP pathway and stimulating NO synthase (NOS)
[18]. Activation of the cytokine/lipopolysaccharide-
inducible NOS causes nitrite increase, p53 accumula-
tion and DNA fragmentation, which is prevented by
NG-monomethyl-L-arginine (NMMA), NOS inhibi-
tor [16]. In addition, NO donor can induce p53 ac-
cumulation and trigger apoptosis [15,19]. Transfec-
tion with replication defective adenovirus encoding
p53 and bcl-2 genes proved that p53 alone is su⁄-
cient to trigger apoptosis of ventricular myocytes
while expression of bcl-2 prevents ventricular myo-
cyte death and apoptosis provoked by p53 [21,22].
Bcl-2 can inhibit NO-mediated apoptosis and poly-
(ADP-ribose) polymerase cleavage [20]. Overexpres-
sion of bcl-2 blocks lipid peroxidation completely
and prevents apoptosis [11]. It is also reported that
bcl-2 suppressed apoptosis induced by ischemia-re-
perfusion in intestinal epithelium of transgenic mice
[23]. Therefore, the expression of apoptosis-related
genes, such as bcl-2 and p53, is closely related to
active oxygen species. Antioxidant therapies may be
valuable to prevent apoptosis by means of scaveng-
ing reactive oxygen species and modulating the ex-
pression of bcl-2 and p53 against myocardial ische-
mia-reperfusion injury.
In order to elucidate the relationship between the
antioxidant property of Chinonin and its protective
e¡ects against cardiomyocyte injury, the experiments
were designed to determine apoptotic and necrotic
cell death, the generation of NO and oxygen free
radicals, as well as the expression of bcl-2 and p53
to clarify whether Chinonin scavenges active oxygen
species and alters expression levels of apoptosis-mod-
ulating genes in hypoxia-reoxygenated cardiomyo-
cytes.
2. Materials and methods
2.1. Cell culture
Neonatal rat cardiomyocytes were cultured ac-
cording to the method described by Tanaka with
minor modi¢cations [4]. In brief, the hearts from
2^3-day Wistar rats (the First Military Medical Uni-
versity Medical Zoology Center) were minced and
dissociated with 0.06% trypsin (Advanced Techno-
logical and Industrial Company, UK). The dispersed
cells were incubated on 100-mm culture dishes for 15
min at 37‡C with 100% relative humidity in a CO2
incubator. Non-attached viable cells were collected
and incubated in DMEM (Kibbutz Beit Haemek Is-
rael) supplemented with 10% FCS (Kibbutz Beit
Haemek Israel), penicillin (50 U/ml) and streptomy-
cin (50 Wg/ml) for 6 h, followed by incubation in the
same media supplemented with 1036 mol/l cytosine
Fig. 1. Chemical structure of Chinonin.
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arabinoside (Ara C, Sigma) for 48 h to reduce the
rate of non-myocytes. And then, the cultured media
were replaced by DMEM supplemented with 1%
FCS and the cells were incubated for 24 h. Since
NO is reactive in oxygenated aqueous solution and
decomposes to nitrite and nitrate, the accumulated
NO32 /NO
3
3 in culture medium is taken as an indirect
index of endogenous NO production. Meanwhile,
thiobarituric acid reaction substances (TBARS) rep-
resents lipid preoxidation injury on membrane at-
tacked by oxygen free radicals and LDH is a classic
index of cell damage. In order to measure NO32 /
NO33 , TBARS and LDH contents, the cultured me-
dia were replaced by DMEM without phenol red
(Sigma) supplemented with 5% FCS before hypoxia.
Di¡erent doses of Chinonin (1, 10, 100 Wmol/l, 999
Enterprise Group, Medical and Pharmaceutical Re-
search Institute) were added into the cultured media.
The cardiomyocytes were incubated at 37‡C in an
air-tight incubator where normal air was replaced
by 95% N2/5% CO2 for 24 h to produce hypoxia,
and then the air was replaced by 95% O2/5% CO2
for 4 h to produce reoxygenation. Correspond-
ing control cells were incubated under the same
conditions, but kept in normoxia (ambient atmos-
phere).
2.2. Analysis of DNA fragmentation
After hypoxia and reoxygenation, the cells were
washed twice with PBS and precipitated by centrifu-
gation. The cells were incubated with lysis bu¡er
(0.2 mol/l Tris-HCl, pH 8.0; 0.1 mol/l Na2EDTA;
1% SDS and 100 mg/l proteinase K) for 4 h at
55‡C. The nuclear lysates were extracted twice with
phenol and then extracted with an equal volume of
phenol^chloroform^isoamyl alcohol (25:24:1). DNA
was precipitated with 0.05 volume of 5 mol/l sodium
chloride and 2.5 volume of ethanol overnight at
320‡C and sedimented at 10 000 rpm for 10 min
at 4‡C. The DNA was incubated with TE bu¡er
(10 mmol/l Tris-HCl, pH 7.5; 1 mmol/l Na2EDTA)
containing 20 mg/l RNase A for 1 h at 37‡C. The
DNA was ¢nally extracted twice with equal volume
of phenol^chloroform^isoamyl alcohol (25:24:1).
After being washed with 75% ethanol, DNA samples
were analyzed by electrophoresis on 1.5% agarose
gels with TAE bu¡er (40 mmol/l Tris-HCl, 20
mmol/l acetic acid, and 1 mmol/l Na2EDTA). The
gel was stained with 0.5 Wg/ml ethidium bromide
and photographed by UV transillumination.
2.3. Detection of DNA fragmentation by ELISA
Cellular DNA fragmentation was determined us-
ing the cell death detection ELISA reagents (Boehr-
inger Mannheim, Mannheim) following the manufac-
turer’s instructions. The DNA fragmentation was
expressed in the enrichment of histone-associated
mono- and oligonucleosomes released into the cyto-
plasm. The enrichment factor (EF) was calculated
according to absorption at 405 nm, which repre-
sented the enrichment of histone-associated DNA
fragmentation and accounted for apoptosis of cardi-
omyocytes.
2.4. Annexin-V-FLUOS/propidium iodide (PI) double
staining cytometry
Annexin V is a Ca2-dependent phospholipid-
binding protein with high a⁄nity for phosphatidyl-
serine (PS). It is used as a sensitive probe for PS
exposure upon the outer lea£et of the cell membrane
and is therefore suitable to detect apoptotic cells.
When annexin V is simultaneously applied with PI,
it can di¡erentiate necrotic cells from apoptotic
cells. Double staining for Annexin-V-FLUOS/PI
was performed as Vermes et al. described [24]. In
brief, after being washed twice with PBS, 106 myo-
cyte cells were resuspended in binding bu¡er
(10 mmol/l HEPES/NaOH, pH 7.4, 140 mmol/l
NaCl, 2.5 mmol/l CaCl2). Annexin V-FLUOS
(Boehringer Mannheim) and PI (Sigma) were respec-
tively added to a ¢nal concentration of 1 Wg/ml in
cell suspension. The mixture was incubated for
20 min in the dark at room temperature and then
measured by FACScan (EPICS Elite). Annexin-V-
FLUOS/PI3 and Annexin-V-FLUOS/PI cell
populations were calculated.
2.5. p53 and bcl-2/DNA staining cytometry
Bcl-2 and p53 proteins were detected as Steck de-
scribed with minor modi¢cation [25]. Fixed cells were
washed two times in PBS containing 4% BSA (PBS/
BSA). The 1:50 dilution of the primary antibodies,
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bcl-2 (N-19, Santa Cruz) and p53 (CM-1, Novo)
were added respectively to the cell pellet and placed
at 4‡C for 60 min. The cells were then washed in
PBS/BSA and incubated in a 1:50 dilution of the
secondary antibody, goat-antimouse FITC (Doko),
for 60 min. Excess antibody was rinsed and the cells
were resuspended in PBS supplemented with PI (10
Wg/ml) and RNase (1.0 mg/ml). Samples were ana-
lyzed using FACScan (EPICS Elite). At least 5000
cells were detected for each sample.
2.6. Nitrite and nitrate determination
NO production was measured as nitrite accumula-
tion in the media from the hypoxia-reoxygenated
cardiomyocytes. The concentrations of NO32 /NO
3
3
in culture supernatants were quantitated as Yu de-
scribed with minor modi¢cation [26]. In brief, cul-
tured supernatant (200 Wl) was incubated with 100
Wl of nitrate reductase (90 mU/ml, Sigma), 100 Wl
nicotinamide adenine dinucleotide phosphate
(NADPH, 0.28 mmol/l, Sigma), 100 Wl of £avin ad-
enine dinucleotide (FAD 35 Wmol/l, Sigma) and 200
ml of potassium phosphate bu¡er (0.1 mol/l, pH 7.5)
for 60 min at 25‡C. After boiling for 3 min, an equal
volume of Griess reagent (1:1 mixture of 2% sulfa-
nilamide in 5% H3PO4 and 0.2% N-(1-naphthyl)-
ethylenediamine dihydrochloride in water) was added
to the reduced samples and incubated at 60‡C for
10 min. The absorption at 550 nm was measured
using Bio-Rad 450 ELISA reader. A standard curve
(0^18 nmol/mg per tube) of sodium nitrate (Sigma)
in 200 Wl of potassium phosphate bu¡er (0.1 mol/l,
pH 7.5) was included with each assay.
2.7. TBARS measurement
The concentrations of TBARS in supernatants
were measured by means of Ohkawa’s method [27]
at 532 nm using Beckman DU-640 spectrophotome-
ter.
2.8. LDH measurement
The activities of LDH in supernatants were meas-
ured by means of the enzyme dynamic method using
Beckman DU 640 spectrophotometer with Zhong
Sheng Biotech standard reagents.
2.9. Statistical analysis
All data are expressed as means þ S.E. and ana-
lyzed by ANOVA. When P6 0.05, statistical signi¢-
cance was accepted.
3. Results
3.1. Protection e¡ects of Chinonin on DNA
fragmentation
As shown in Fig. 2, a ladder pattern of DNA
fragmentation appeared in the cardiomyocytes of
24 h of hypoxia and 24 h of hypoxia followed by
4 h of reoxygenation, which is a characteristics of
apoptosis in DNA electrophoresis on agarose gel.
Cardiomyocytes pretreated with Chinonin showed
that no DNA fragmentation occurred on the agarose
electrophoresis. In order to further evaluate the ef-
fects of Chinonin on DNA fragmentation, the cell
death detection ELISA was used to analyze DNA
degradation quantitatively. With anti-histone mono-
clonal antibody, the histone-associated DNA frag-
mentation (mono- and oligonucleosomes) was de-
tected in the method. As shown in Fig. 3, when the
cells were subjected to 24 h of hypoxia or 24 h of
hypoxia followed by 4 h of reoxygenation, the EF
Fig. 2. Agarose gel electrophoresis analysis on DNA fragmenta-
tion. Lane A, 24 h of hypoxia; lane B, 24 h of hypoxia and 4 h
of reoxygenation (HR); lane C, HO+Chinonin 100 Wmol/l ; lane
D, HR+Chinonin 100 mmol/l ; lane E, control.
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values of DNA fragmentation were increased signi¢-
cantly. In the presence of Chinonin, the EF value
was signi¢cantly reduced in both hypoxic and hy-
poxia-reoxygenated cardiomyocytes in a dose-de-
pendent way. The results indicate that Chinonin
could prevent DNA fragmentation and block cell
death in the process of hypoxia and reoxygenation.
To discriminate necrotic and apoptotic cells, a £ow
cytometric detection of PS expression on early apop-
tosis was employed by using £uorescence-conjugated
annexin V. As shown in Fig. 4, the vital cells are
negative for both £uorescence-conjugated annexin
V binding and PI uptake (annexin V3/PI3). The
apoptotic cells are positive for £uorescence-conju-
gated annexin V binding but negative for PI uptake
(annexin V/PI3), while the necrotic cells are positive
for both £uorescence-conjugated annexin V binding
and PI uptake (annexin V/PI). The statistic data
are showed in Fig. 5. Twenty-four hours of hypoxia
signi¢cantly increased the rates of apoptosis and 24 h
of hypoxia followed by 4 h of reoxygenation further
increased the rates of apoptosis (annexin V/PI3)
and necrosis (annexin V/PI) signi¢cantly. Compar-
ing with the results of 24 h of hypoxia, when the
cardiomyocytes were subjected to 24-h hypoxia and
4-h reoxygenation, the apoptotic rate was increased
about 70%, which was much less than the increase
rate of necrotic (about 460%). The results indicate
that hypoxia mainly induced cardiomyocyte apopto-
sis and reoxygenation not only mediated apoptosis,
but also induced necrosis. When cardiomyocytes
were incubated with Chinonin, the rates of apoptosis
and necrosis were inhibited in a dose-dependent way.
The results demonstrate strongly that Chinonin
could protect cardiomyocytes from hypoxia-reoxyge-
nation injury.
3.2. E¡ects of Chinonin on the production of NO and
TBARS and leakage of LDH
The ability of Chinonin to in£uence the produc-
tion of NO and lipid peroxidation as well as the
leakage of LDH were investigated. As shown in Ta-
ble 1, the level of NO in the media was increased by
hypoxia, but it was decreased by reoxygenation. In
Fig. 3. Enrichment factor (EF) of DNA fragmentation in cul-
tured hypoxia-reoxygenated cardiomyocytes. Control, normal;
HO, hypoxia; HR, hypoxia-reoxygenation; CN1, Chinonin
1 Wmol/l ; CN10, Chinonin 10 Wmol/l ; CN100, Chinonin 100
Wmol/l. #Vs. control, P6 0.05; @vs. HO, P6 0.05; *vs. HR,
P6 0.05.
Table 1





Control 2.47 þ 0.09 4.10 þ 0.21 2.60 þ 0.31
HO 14.28 þ 0.78a 5.33 þ 0.43a 7.82 þ 0.47a
HR 12.32 þ 0.27b 7.41 þ 0.42b 12.77 þ 0.56b
HO+CN (1 Wmol/l) 7.37 þ 0.44b 4.02 þ 0.34b 5.46 þ 0.35b
HO+CN (100 Wmol/l) 3.56 þ 0.22b 3.12 þ 0.24b 4.25 þ 0.24b
HR+CN (1 Wmol/l) 6.25 þ 0.58c 3.68 þ 0.25c 9.32 þ 0.68c
HR+CN (10 Wmol/l) 4.26 þ 0.36c 4.71 þ 0.21c 7.30 þ 0.17c
HR+CN (100 Wmol/l) 3.20 þ 0.35c 4.18 þ 0.22c 5.35 þ 0.23c
HO, hypoxia; HR, hypoxia-reoxygenation.
aVs. control, P6 0.05.
bVs. HO, P6 0.05.
cVs. HR, P6 0.05.
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addition, the levels of TBARS and LDH in the me-
dia were slightly increased by hypoxia and signi¢-
cantly augmented by reoxygenation. The results sug-
gest that hypoxia improved NO production in the
cardiomyocytes, while reoxygenation caused oxygen
burst and led to lipid peroxidation injury. In the
presence of Chinonin, the levels of NO32 /NO
3
3 ,
TBARS and LDH were signi¢cantly decreased in
the media of hypoxia and hypoxia-reoxygenated car-
diomyocytes and it was dose dependent. The results
suggest that Chinonin has antioxidant properties of
scavenging NO and oxygen free radicals during car-
diomyocyte hypoxia and reoxygenation.
3.3. E¡ects of Chinonin on expression of bcl-2 and
p53 proteins
To further elucidate the anti-apoptotic mecha-
nisms of Chinonin against hypoxia-reoxygenation in-
jury, we examined the alteration in the expression
levels of bcl-2 and p53 proteins associated with hy-
poxia and hypoxia-reoxygenation induced cell death.
The changes in the protein levels of p53 and bcl-2 in
response to hypoxia and hypoxia-reoxygenation are
shown in Figs. 6^9. The results revealed that hypoxia
induced the up-regulation of bcl-2 and p53 proteins
in cardiomyocytes, while reoxygenation further up-
regulated p53 protein, but down-regulated bcl-2 pro-
tein. Chinonin down-regulated p53 protein but had
no e¡ect on bcl-2 in hypoxic cardiomyocytes. It also
inhibited signi¢cantly the up-regulation of p53 pro-
tein and the down-regulation of bcl-2 protein in hy-
poxia-reoxygenated cardiomyocytes.
4. Discussion
The results of agarose electrophoresis, cell death
Fig. 4. The cardiomyocytes measured by annexin-V-FLUOS/propidium iodide (PI) double staining cytometry. Region 3 shows the vi-
tal cells which are negative for both annexin V binding and PI uptake (annexin V3/PI3). Region 4 shows the apoptotic cells which
are positive for annexin V binding, but negative for PI uptake (annexin V/PI3). Region 2 shows the necrotic cells which are positive
for both annexin V binding and PI uptake (annexin V/PI). A, negative control; B, normal control ; C, hypoxia (HO); D, hypoxia-
reoxygenation (HR); E, HO+CN 1 Wmol/l ; F, HO+CN 100 Wmol/l, G, HR+CN 1 Wmol/l ; H, HR+CN 100 Wmol/l.
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ELISA detection and FACS analysis of cell binding
annexin V and PI showed that 24 h of hypoxia
caused apoptosis and 24 h of hypoxia followed by
4 h of reoxygenation induced both apoptotic and
necrotic cell death in cultured neonatal rat cardio-
myocytes. Cell death ELISA detection demonstrated
that the EF of histone-associated mono- and oligo-
nucleosomes increased signi¢cantly in both hypoxia
and hypoxia-reoxygenated cardiomyocytes. Further
investigation with FACS analysis provided the evi-
dence that hypoxia caused apoptosis and reoxygena-
tion further increased apoptotic rates and induced
necrosis, indicating that reoxygenation produced
more serious damage in cardiomyocytes. It was fur-
ther demonstrated by monitoring the release of LDH
from cardiomyocytes. When Chinonin was pre-ad-
ministered into the cultured media, the apoptotic
and necrotic rates of cardiomyocytes and LDH leak-
age were signi¢cantly decreased in a dose-dependent
manner. The apoptotic and necrotic rates were al-
most completely inhibited by 100 Wmol/l of Chino-
nin, suggesting that it had strongly protective e¡ects
on the hypoxia-reoxygenated cardiomyocytes. In ad-
dition, FACS detection showed that 1 Wmol/l of Chi-
nonin decreased signi¢cantly apoptotic and necrotic
rates, but cell death ELISA detection did not show
the e¡ect on EF of DNA fragmentation. The dis-
crepancy of two detective methods may be attributed
to the di¡erent sensitivity in detection of apoptosis
and di¡erent biochemical criteria. As previous de-
scribed, annexin V is a Ca2-dependent phospholip-
id-binding protein with high a⁄nity for PS. Early
stage(s) of apoptosis may be implicated in the loss
of membrane phospholipid asymmetry and appear-
ance of PS, normally found in the inner lea£et of
plasma membrane, on the outer surface of cells
[36]. The PS translocation is believed to be the hall-
mark of apoptosis [37]. A recent study demonstrated
the PS externalization in plasma membranes from
ischemic and ischemia-reperfused hearts [36]. The de-
Fig. 5. Rates (%) of apoptosis and necrosis in cultured hypo-
xia-reoxygenated cardiomyocytes measured by annexin-V-
FLUOS/propidium iodide (PI) double staining cytometry. Con-
trol, normal; HO, hypoxia; HR,hypoxia-reoxygenation; CN1,
Chinonin 1 Wmol/l ; CN10: Chinonin 100 Wmol/l ; CN100, Chi-
nonin 100 Wmol/l. #Vs. control, P6 0.05; @vs. HO, P6 0.05;
*vs. HR, P6 0.05.
Fig. 6. Flow cytometry measurement of expression level of bcl-2 protein. A, negative control; B, normal control ; C, hypoxia (HO);
D, hypoxia-reoxygenation (HR); E, HO+CN 1 Wmol/l ; F, HO+CN 100 Wmol/l, G, HR+CN 1 Wmol/l ; H, HR+CN 100 Wmol/l.
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tection of the PS externalization to report apoptosis
may be more sensitive than the measurement of his-
tone-associated DNA fragmentation.
It is well known that oxidative stress leads cells to
the exposure of reactive oxygen species, such as
superoxide, hydroxyl radicals, NO and peroxynitrite
(ONOO3), and triggers apoptotic cellular death
process [11,12,14,28]. Antioxidants may prevent
apoptosis by means of suppressing or scavenging re-
active oxygen species [11,12,29]. The current study
provided new evidence that antioxidant could protect
cells from oxidant damage and block apoptotic and
necrotic cell death. In this study, the level of NO32 /
NO33 in the media was increased by hypoxia, but
decreased by reoxygenation. It suggested that hyp-
oxia caused the generation of NO from cardiomyo-
cytes and reoxygenation reduced the level of NO in
cardiomyocytes. Previous studies revealed that hyp-
oxia stimulated and up-regulated NO synthase gene
expression and modulated guanylate cyclase in car-
diomyocytes [30,31]. The augmentation of NO pro-
duction in the hypoxic cardiomyocytes may be due
to the activation of NOS in response to hypoxia.
Other possible explanations could be that the acidic
condition in hypoxic cardiomyocytes might be re-
sponsible for NO accumulation. NO can also be gen-
erated in tissues or cells by either direct dispropor-
tion or reduction of nitrite to NO under the acidic
and highly reduced conditions, such as ischemia or
hypoxia. It has been demonstrated that the enzyme-
independent mechanism not only contributes to post-
ischemic myocardial injury, but it may also reverse
the protective e¡ects of NOS blockers [32]. When
oxygen was re-introduced for the hypoxic cardio-
myocytes, oxygen burst might generate large
amounts of superoxide anions, and in consequence
induce lipid peroxidation injury. Our data showed
that the level of TBARS in the media was slightly
increased by hypoxia and accumulated remarkably
by reoxygenation, which suggested indirectly that
the large amount of oxygen radicals was generated
Fig. 7. Expression rates (%) of bcl-2 protein in hypoxia-reoxy-
genated cardiomyocytes. Control, normal; HO, hypoxia; HR,
hypoxia-reoxygenation; CN1, Chinonin 1 Wmol/l ; CN10, Chi-
nonin 10 Wmol/l ; CN100, Chinonin 100 Wmol/l. #Vs. Control,
P6 0.05; @vs. HO, P6 0.05; *vs. HR, P6 0.05.
Fig. 8. Flow cytometry measurement of expression level of p53 protein. A, negative control; B, normal control ; C, hypoxia (HO);
D, hypoxia-reoxygenation (HR); E, HO+CN 1 Wmol/l ; F, HO+CN 100 Wmol/l, G, HR+CN 1 Wmol/l ; H, HR+CN 100 Wmol/l.
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from reoxygenated cardiomyocytes. In addition, the
reaction of superoxide with NO results in the forma-
tion of ONOO3, which is associated with the cyto-
toxic mechanism of NO. The decrease of detectable
NO may be attributed to the generation of oxygen
radicals in reoxygenated cardiomyocytes. Moreover,
our data showed that hypoxia induced mainly cell
apoptosis while reoxygenation led to both apoptotic
and necrotic cell death in cultured cardiomyocytes. It
was reported that down-regulation of CuZn-SOD led
to cell death via the NO/ONOO3 pathway, suggest-
ing that the cytotoxicity of NO was related to the
formation of ONOO3 [34]. Large amounts of
ONOO3 rapidly lead to necrotic cell death, whereas
smaller amounts promote apoptosis [35]. Therefore,
the possible mechanisms of apoptosis occurring in
hypoxia may be associated with the formation of
NO, and the apoptosis and necrosis appearing in
reoxygenated cardiomyocytes may be contributed
by the formation of oxygen radicals and ONOO3.
In the presence of Chinonin, the levels of NO and
TBARS were signi¢cantly decreased in the media of
hypoxia and hypoxia-reoxygenated cardiomyocytes,
suggesting that Chinonin could scavenge NO and
inhibit the reaction of lipid peroxidation. In the
chemical structure of Chinonin, there are four hy-
droxyl groups, which can react with reactive oxygen
species to form a stable semiquinone free radicals so
as to reduce their cytotoxicity. Chinonin can scav-
enge oxygen radicals and NO and inhibit the oxida-
tive activity of ONOO3 [1]. The study of Langen-
dor¡ ischemia-reperfused hearts also revealed that
Chinonin could inhibit the leakage of lactase dehy-
drogenase (LDH) and creatine kinase and prevent
myocardial damage [1]. The current study further
proved the antioxidant properties of Chinonin of
scavenging NO and oxygen free radicals and the car-
dioprotective e¡ects on hypoxia-reoxygenated cardi-
omyocytes. Therefore, the scavenging e¡ects on ac-
tive oxygen species may contribute to the anti-
apoptotic mechanisms of Chinonin in hypoxia and
hypoxia-reoxygenated cardiomyocytes.
Hypoxia-reoxygenation is di¡erent from ischemia-
reperfusion. In the experiment of hypoxia-reoxygena-
tion, DMEM medium with 5% FCS and glucose was
used and the apoptosis of cardiocyte in this medium
was just caused by hypoxia and reoxygenation with-
out metabolic inhibition and energy default as was
the case in ischemia-reperfusion heart.
Active oxygen species may also trigger apoptotic
process by means of adjusting the apoptotic related
genes, such as bcl-2 and p53, in myocardial ischemia-
reperfusion injury. It is well known that bcl-2 and
p53 are involved in regulating apoptotic process. The
function of bcl-2 as a survival gene is responsible for
inhibiting cell death by acting as an antioxidant, trig-
gering enhanced expression of cellular antioxidant
defense. It may also act directly by inhibition of
the generation of oxygen radicals [33]. In addition,
bcl-2 can inhibit NO-mediated apoptosis and poly-
(ADP-ribose) polymerase cleavage [20]. As pro-apop-
totic gene, p53 may play critical roles in triggering
the apoptotic program of cells in hypoxic-mediated
cellular apoptosis [15,19]. NO donor induced p53
accumulation and triggered apoptosis, and NOS in-
hibitor NMMA prevented apoptosis and down-regu-
lated p53 accumulation [16]. The current study
showed that hypoxia up-regulated the expression lev-
els of bcl-2 and p53 proteins and reoxygenation fur-
ther up-regulated the expression level of p53, but
down-regulated the expression level of bcl-2. Chino-
nin up-regulated the expression level of bcl-2 protein
in hypoxia-reoxygenated cardiomyocytes and down-
regulated the expression level of p53 protein in both
hypoxic and hypoxia-reoxygenated cardiomyocytes.
Chinonin has antioxidant properties of scavenging
NO and oxygen free radicals, the modulation of
bcl-2 and p53 proteins may be related to the anti-
Fig. 9. Expression rates (%) of p53 protein in cultured hypoxia-
reoxygenated cardiomyocytes. Control, normal; HO, hypoxia;
HR, hypoxia-reoxygenation; CN1, Chinonin 1 Wmol/l ; CN10,
Chinonin 10 Wmol/l ; CN100, Chinonin 100 Wmol/l. #Vs. Con-
trol, P6 0.05; @vs. HO, P6 0.05; *vs. HR, P6 0.05.
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oxidant properties of Chinonin. Therefore, the anti-
apoptotic mechanisms of Chinonin may regulate the
expression levels of bcl-2 and p53 in hypoxia-reoxy-
genated cardiomyocytes.
Acknowledgements
The work was supported by a grant from the Na-
tional Natural Science Foundation of China.
References
[1] B.L. Zhao, J.G. Shen, M. Li, M.F. Li, Q. Wan, W.J. Xin,
Biochim. Biophys. Acta 1315 (1996) 131^137.
[2] H.P. Li, Z.G. Fu, M. Li, Y. Xiang, X.M. Xia, Respirology 3
(2) (1998) 87^94.
[3] J. Searle, J.F. Kerr, C.J. Bishop, Pathol. Annu. 17 (1982)
229^259.
[4] M. Tanaka, H. Ito, S. Adachi, H. Akimoto, T. Nishikawa,
T. Kasajima, F. Marumo, M. Hiroe, Circ. Res. 75 (3) (1994)
426^433.
[5] R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior,
R.L. Engler, J. Clin. Invest. 94 (1994) 1621^1628.
[6] R.H. Bardales, L.S. Hailey, S.S. Xie, R.F. Schaefer, S.M.
Hsu, Am. J. Pathol. 149 (3) (1996) 821^829.
[7] T. Tominaga, S. Kure, K. Narisawa, T. Yoshimoto, Brain
Res. 608 (1993) 21^26.
[8] K. Fukuda, M. Kojiro, J.F. Chiu, Am. J. Pathol. 142 (1993)
935^946.
[9] M. Schumer, M.C. Colombel, C. Sawczuk, Am. J. Pathol.
140 (1992) 831^836.
[10] J. Kajstura, W. Cheng, K. Reiss, A.W. Clark, E.H. Sonnen-
blick, S. Krajewski, C.J. Reed, G. Olivetti, P. Anversa, Lab.
Invest. 74 (1) (1996) 86^107.
[11] D.M. Heockenbery, Z.N. Oltvai, X.-M. Yin, C.L. Milliman,
S.J. Krosmeyer, Cell 75 (1993) 241^251.
[12] D.J. Kane, T.A. Sara¢an, R. Anton, Science 262 (1993)
1274^1277.
[13] T. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J.
Koch, S.W. Lowe, A.J. Giaccia, Nature 379 (1996) 88^91.
[14] P.A. Sandstrom, M.D. Mannie, T.M. Buttke, J. Leukocyte
Biol. 55 (1994) 221^226.
[15] U.K. Messmer, B. Brune, Arch. Biochem. Biophys. 327 (1)
(1996) 1^10.
[16] U.K. Messmer, D.M. Reimer, J.C. Reed, B. Brune, FEBS
Lett. 384 (2) (1996) 162^166.
[17] B. Ho¡man, D.A. Liebermann, Oncogene 9 (1994) 1807^
1812.
[18] M. Kitakaze, K. Node, K. Komamura, T. Minamino, M.
Inoue, M. Hori, T. Kamada, J. Mol. Cell Cardiol. 27 (1995)
2149^2154.
[19] U.K. Messmer, M. Ankarcrona, P. Nicotera, B. Brune,
FEBS Lett. 355 (1994) 23^26.
[20] Z. Melkova, S.B. Lee, D. Rodriguez, M. Esteban, FEBS
Lett. 403 (3) (1997) 273^278.
[21] L.A. Kieshenbaum, D. De Moissac, Circulation 96 (5) (1997)
1580^1585.
[22] A. Stempien-Otero, A. Karsan, C.J. Cornejo, H. Xiang, T.
Eunson, R.S. Morrison, M. Kay, R. Winn, J. Harlan, J. Biol.
Chem. 274 (12) (1999) 8039^8045.
[23] C.M. Coopersmith, D. O’Donnell, J.I. Gordon, Am. J. Phys-
iol. 276 (3 pt 1) (1999) G677^686.
[24] I. Vermes, C. Haanen, H. Ste¡ens-Nakken, C. Reuteling-
sperger, J. Immunol. Methods 184 (1995) 39^51.
[25] K. Steck, T. McDonnell, N. Sneige, A. El-Naggar, Cytom-
etry 24 (1996) 116^122.
[26] L. Yu, P.E. Gengaro, M. Niederberger, T.J. Burke, R.W.
Schrier, Proc. Natl. Acad. Sci. USA 91 (1994) 1691^1698.
[27] H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 95 (1979)
351^358.
[28] S. Dimmeler, A.M. Zeiher, Nitric Oxide 1 (4) (1997) 275^
281.
[29] K. Kashima, S. Yokoyama, T. Daa, I. Nakayama, T. Iwaki,
Virchows Arch. 430 (4) (1997) 333^338.
[30] M. Kitakaze, K. Node, K. Komamura, T. Minamino, M.
Inoue, M. Hori, T. Kamada, J. Mol. Cell Cardiol. 27 (10)
(1995) 2149^2154.
[31] B. Gess, M. Schricker, A. Kurtz, Am. J. Physiol. 273 (3 Pt 2)
(1995) R905^910.
[32] J.L. Zweier, A. Samouilov, P. Kuppusamy, Biochim. Bio-
phys. Acta 1411 (1999) 250^262.
[33] H.J. Bromme, J. Holtz, Mol. Cell Biochem. 163/164 (1996)
261^275.
[34] C.M. Troy, D. Derossi, A. Prochiantz, L.A. Greene, M.L.
Shelanski, J. Neurosci. 16 (10) (1996) 253^261.
[35] M.P. Murphy, Biochim. Biophys. Acta 1411 (1999) 401^414.
[36] N. Maulik, V.E. Kagan, V.A. Tyurin, D.K. Das, Am. J.
Physiol. 274 (Heart. Circ. Physiol. 43) (1998) H242-H248.
[37] D. Geldwerth, F.A. Kuypers, P. Butikofer, M. Allary, B.H.
Lubin, P.F. Devaux, J. Clin. Invest. 92 (1993) 308^314.
BBADIS 61909 20-1-00
J.-G. Shen et al. / Biochimica et Biophysica Acta 1500 (2000) 217^226226
